Subcutaneous erythropoietin results in lower dose and equivalent hematocrit levels among adult hemodialysis patients: Results from the 1998 End-Stage Renal Disease Core Indicators Project.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples